Global Biopharmaceutical Contract Manufacturing Industry is expected to reach a startling US$ 25.1 Billion by 2034, with a compound annual growth rate of 8.8% | FMI
The Global Biopharmaceutical Contract Manufacturing Industry is on track for a significant surge, driven by